Noninvasive assessment of renal fibrosis by magnetic resonance imaging and ultrasound techniques.

Renal fibrosis is a useful biomarker for diagnosis and guidance of therapeutic interventions of chronic kidney disease (CKD), a worldwide disease that affects more than 10% of the population and is one of the major causes of death. Currently, tissue biopsy is the gold standard for assessment of rena...

Descripción completa

Detalles Bibliográficos
Publicado en:Translational Research: The Journal of Laboratory & Clinical Medicine Vol. 209; pp. 105 - 121
Autores principales: Jiang, Kai, Ferguson, Christopher M., Lerman, Lilach O.
Formato: research Journal Article
Publicado: Elsevier B.V. Jul2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=136712040&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 136712040
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        19315244
        2Q66
      jtl: Translational Research: The Journal of Laboratory & Clinical Medicine
      issn: 19315244
      maglogo: N
    pubinfo:
      dt: Jul2019
      vid: 209
      pid: 467
      pub: Elsevier B.V.
      place: New York, New York
    artinfo:
      ui:
        136712040
        136712040
        NLM31082371
        136712040
        10.1016/j.trsl.2019.02.009
        NLM31082371
        136712040
      ppf: 105
      ppct: 16
      formats:
      tig:
        atl: Noninvasive assessment of renal fibrosis by magnetic resonance imaging and ultrasound techniques.
      aug:
        au:
          Jiang, Kai
          Ferguson, Christopher M.
          Lerman, Lilach O.
        affil: Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota
      sug:
        subj:
          Kidney Pathology
          Kidney
          Ultrasonography
          Magnetic Resonance Imaging
          Fibrosis
          Human
          Oxygen Blood
          Clinical Assessment Tools
          Scales
      ab: Renal fibrosis is a useful biomarker for diagnosis and guidance of therapeutic interventions of chronic kidney disease (CKD), a worldwide disease that affects more than 10% of the population and is one of the major causes of death. Currently, tissue biopsy is the gold standard for assessment of renal fibrosis. However, it is invasive, and prone to sampling error and observer variability, and may also result in complications. Recent advances in diagnostic imaging techniques, including magnetic resonance imaging (MRI) and ultrasonography, have shown promise for noninvasive assessment of renal fibrosis. These imaging techniques measure renal fibrosis by evaluating its impacts on the functional, mechanical, and molecular properties of the kidney, such as water mobility by diffusion MRI, tissue hypoxia by blood oxygenation level dependent MRI, renal stiffness by MR and ultrasound elastography, and macromolecule content by magnetization transfer imaging. Other MR techniques, such as T1/T2 mapping and susceptibility-weighted imaging have also been explored for measuring renal fibrosis. Promising findings have been reported in both preclinical and clinical studies using these techniques. Nevertheless, limited specificity, sensitivity, and practicality in these techniques may hinder their immediate application in clinical routine. In this review, we will introduce methodologies of these techniques, outline their applications in fibrosis imaging, and discuss their limitations and pitfalls.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N